Effective mast cell degranulating peptide inhibitors of the IgE/FcεRI receptor interaction

Chemical Biology and Drug Design

Volumn 72, Issue 2, 2008, Pages 133-139

  Buku, Angeliki ^a   Keselman, Inna ^a   Lupyan, Dmitry ^a   Mezei, Mihaly ^a   Price, Joseph A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

hexosaminidase; Fc RI receptor; Fluorescence binding; IgE; MCD peptides

Indexed keywords

ALANINE; ARGININE; BETA N ACETYLHEXOSAMINIDASE; CELL RECEPTOR; FC EPSILON RECEPTOR I; FC RECEPTOR; HISTIDINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN RECEPTOR; INHIBITOR PROTEIN; LEUCINE; LYSINE; MAST CELL DEGRANULATING PEPTIDE; MAST CELL DEGRANULATING PEPTIDE 2; MAST CELL DEGRANULATING PEPTIDE 3; MAST CELL DEGRANULATING PEPTIDE 4; MAST CELL DEGRANULATING PEPTIDE 5; MAST CELL DEGRANULATING PEPTIDE 6; MAST CELL DEGRANULATING PEPTIDE 7; MAST CELL DEGRANULATING PEPTIDE 8; MAST CELL DEGRANULATING PEPTIDE INHIBITOR; PROLINE; VALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG SYNTHESIS; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE, TUMOR; CIRCULAR DICHROISM; IMMUNOGLOBULIN E; MODELS, MOLECULAR; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, IGE;

EID: 47949124268     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00684.x     Document Type: Article

References (39)

1. Eder W., Ege M.J., Van Mutius E. (2006) The asthma epidemic. N Engl J Med 355 : 2226 2235.
2. Sallivan A.F., Schatz M., Wentzel S.E., Vanderweil S.G., Camago C.A. (2007) A profile of U.S. asthma centers. Ann Allergy Asthma Immun 99 : 419 423.
3. Metcalfe D.D., Baram D., Mekori Y.A. (1997) Mast cells. Physiol Rev 77 : 1033 1079.
4. Austen F.K. (1982) Tissue mast cells in immediate hypersensitivity. Hospital Practice 17 : 98 108.
5. Shields R.L., Wether W.R., Zioncheck K., O'Connell L., Fendry B., Presta L.G., Thomas D., Saban R., Jardieu P. (1995) Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 107 : 308 312.
6. McDonell J.M., Beavil A.J., Mackay G.A., Jameson B.A., Korngold R., Gould H.J., Sutton B.J. (1996) Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nature Struct Biol 3 : 419 426.
7. Helm B.A., Spivey A.C., Padlan E.E. (1996) Peptide blocking of IgE/receptor interaction: possibilities and pitfalls. Allergy 52 : 1155 1169.
8. Dahno W., Makofske R., Swistok J., Mallamaci M., Nettletton M., Madison V., Greely D., Fry D., Kochan J. (1999) High affinity IgE receptor α-subunit derived peptides as antagonist of human IgE binding. In : Tam J.P., Kaumaya P.T.P., editors. Peptides. Dordrecht : Kluwer Academic Publishers p. 539 540.
9. Nakamura G.R., Starovasnik M.A., Reynolds M.E., Lowman H.B. (2001) A novel family of hairpin peptides that inhibit IgE activity by binding to the high-affinity IgE receptor. Biochemistry 40 : 9828 9835.
10. Buku A. (1999) Mast cell degranulating peptide: a prototypic peptide in allergy and inflammation. Peptides 20 : 415 420.
11. Buku A., Price J.A., Mendlowitz M., Masur S. (2001) Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding. Peptides 22 : 1993 1998.
12. Buku A., Price J.A. (2001) Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release. Peptides 22 : 1987 1991.
13. Buku A., Mendlowitz M., Condie B.A., Price J.A. (2003) Histamine -releasing activity and binding to the FcεRIα human mast cell receptor subunit of mast cell degranulating peptide analogs with alanine substitutions. J Med Chem 46 : 3008 3012.
14. Buku A., Mendlowitz M., Condie B.A., Price J.A. (2004) Partial alanine scan of mast cell degranulating Peptide (MCD): Importance of the histidine-and arginine residues. J Pept Sci 10 : 313 317.
15. 12]℧CD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors. J Pept Res 66 : 132 137.
16. Hruby V.J. (2002) Designing peptide receptor agonists and antagonists. Nature Reviews/Drug Discovery 1 : 847 858.
17. Samant M.P., Hong D.J., Croston G., Rivier C., Revier J. (2006) Novel analogues of Degarelix incorporating hydroxy-, methoxy- and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III. J Med Chem 49 : 3536 3543.
18. Price J.A. (1997) Microplate assay for measurement of histamine release from mast cells. Biotechniques 22 : 958 962.
19. Barsumian E.L., Isersky C., Petrino M.G., Siraganian R.P. (1981) IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and non-relaesing clones. Eur J Immunol 149 : 317 323.
20. Wiegand T.W., Williams P.B., Dreskin S.C., Jouvin M.H., Kinet J.P., Tasset D. (1996) High-affinity oligonucleotide ligands to human IgE inhibit binding to Fcε receptor I. J Immunol 157 : 221 230.
21. Nechansky A., Robertson M.W., Albrecht B.A., Apgar J.R., Kricek F. (2001) Inhibition of antigen mediator release from IgE-sensitized cells by monoclonal anti-FcεRI α-chain receptor antibody: Implications for the involvement of the membrane-proximal α-chain region in FcεRI-mediated cell activation. J Immunol 166 : 5979 5990.
22. Chen Y.H., Jang J.T., Chau K.H. (1974) Determination of α-helix and β-form of protein in aqueous solution by circular dichroism. Biochemistry 13 : 3350 3359.
23. Xu X., Nelson J.W. (1993) Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry. Prot St FunGen 17 : 124 137.
24. Sali A., Blundell T.L. (1993) Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 234 : 779 815.
25. Eramian M., Shen M., Devos D., Melo F., Sali A., Marti-Renom M.A. (2006) A composite score for predicting errors in protein structure models. Prot Sci 15 : 1653 1666.
26. Humphrey W., Dalke A., Schulten K. (1996) VMD:Visual Molecular Dynamics. J Mol Graph 14 : 33 38.
27. Phillips J.C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R.D., Kalé L., Schulten K. (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26 : 1781 1802.
28. Mackerell A.D., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S. et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Physic Chem 102 : 3586 3617.
29. Darden T., York L., Pedersen L. (1993) Particle mesh Ewald: An N-log(N)method for Ewald sums in large systems. J Chem Phys 98 : 10082 10092.
30. Cochrane D.E. (1990) Peptide regulation of mast cell function. Prog Med Chem 27 : 143 189.
31. Fügner A. (1977) Inhibition of antigen-induced histamine release by beta-andrenergic stimulants in vivo. Int Arch Allergy Appl Immunol 54 : 78 87.
32. Sedlin D.C., Adelman S., Austen K.F. (1985) Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc Nat Acad Sci 92 : 3871 3875.
33. Ra C., Kuromitsu S., Hirose T., Yasuda S., Furuichi K., Okumura K. (1992) Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. Int Immunol 5 : 47 54.
34. MacGlasen D.W., Peters S.P., Warner J., Lichtenstein L.M. (1986) Characteristics of human basophil sulfopeptide leucotrien release: releasability defined as the ability of the basophil to respond to dimeric cross-linking. J Immunol 136 : 2231 2239.
35. Garman S.C., Kinet J.-P., Jardetzky T.S. (1998) Crystal structure of the human high-affinity IgE receptor. Cell 95 : 951 961.
36. Buku A., Mirza U., Polewski K. (1994) Circular dichroism (CD) studies on biological activity of mast cell degranulating (MCD) peptide analogs. Int J Pept Prot Res 44 : 410 413.
37. Steinmetz E., Bianco T.I., Zollinger M., Pesiri D. (1994) Characterization of multiple forms of mast cell degranulating peptide by NMR spectroscopy. Pept Res 7 : 77 82.
38. Chen Y., Mant C.T., Hodges R.S. (2001) Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic α-helix. J Pept Res 59 : 18 33.
39. Krause E., Bienert M., Schieder P., Wenschuh H. (2000) The helix propensity scale of D-amino acids: The influence of side chain steric effects. J Am Chem Soc 122 : 4865 4870.